Published November, 2012
By Elizabeth A. DiGangi and Megan K. Moore
Publisher: Elsevier (Academic Press Inc)
Rating:
Availability: Available

Showing you how to conduct research in general, this title also reveals how research is specifically conducted within human skeletal biology. It outlines the advanced types of research being conducted within each sub-specialty of skeletal biology, and gives the reader the tools to set up a research project in skeletal biology.

---

Published November, 2012
By Wen-Quan Zou and Pierluigi Gambetti
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

Transmissible spongiform encephalopathies (TSE), now broadly known as prion diseases, have been recognized for nearly 300 years in animals and almost 100 years in humans.

---

Published November, 2012
By Volker Schumpelick, Jorg-Rudiger Siewert, Matthias Rothmund, J. R. Siewert and Joerg Rudiger Siewert
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

In dem Band sind alle chirurgisch relevanten Erkrankungen der endokrinen Organe umfassend dargestellt: von der Physiologie und Pathophysiologie der endokrinen Regelkreise uber Diagnostik und interdisziplinare Therapie bis hin zu detaillierten Empfehlungen zum Vorgehen und zur Verfahrenswahl.

---

Published November, 2012
By Wen-Quan Zou and Pierluigi Gambetti
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

Volume II covers the etiology, pathogenesis, classification, histopathological and clinical aspects of animal and human prion diseases, including decontamination of prions and development of therapeutics for prion diseases, such as immunomodulation.

---

Published November, 2012
By Christian Rommel, Bart Vanhaesebroeck and Peter K. Vogt
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Current Topics in Microbiology and Immunology
Rating:
Availability: Available

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress.

---

Published November, 2012
By Kenneth Maiese and Stephen Bondy
Publisher: Springer (Humana Press Inc.)
Series: Oxidative Stress in Applied Basic Research and Clinical Practice
Rating:
Availability: Available

Features that characterize the aging process include the gradual accumulation of cell damage after prolonged exposure to oxidative and inflammatory events over a lifetime. Aging and Aging-Related Disorders examines the interface between normal and pathological aging, and illustrates how this border can sometimes be diffuse.

---

Published November, 2012
By Werner-Klaus Waldhäusl, F. A. Gries and Werner A. Scherbaum
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

---

Published November, 2012
By Po Sing Leung
Publisher: Springer
Series: Advances in Experimental Medicine and Biology
Rating:
Availability: Available

Highlighting the role local renin-angiotensin systems (RAS) play in pancreatic disease, this review presents the latest research advances in the field. These findings suggest both preventative measures and treatment for pancreatic disease.

---

Published November, 2012
By Volker A. Erdmann, Jan Barciszewski and hab. Jan Barciszewski
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: RNA Technologies
Rating:
Availability: Available

RNA technologies are the driving forces of modern medicine and biotechnology. It covers various aspects of RNA interference and microRNAs, although antisense RNA applications, hammerhead ribozyme structure and function as well as non-coding RNAs are also discussed.

---

Published November, 2012
By M. Celeste Simon
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Current Topics in Microbiology and Immunology
Rating:
Availability: Available

Although severe hypoxia is generally toxic for both normal tissue and tumors, neoplastic cells gradually adapt to prolonged hypoxia though additional genetic and genomic changes with a net result that hypoxia promotes tumor progression and therapeutic resistance.

---